Company / Interest Expense per Share
Charles River Laboratories Interest Expense per Share History
FY2016-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$1.45
FY2023
5-year range
$1.22 / $1.71
FY2019-FY2023
Trend
-15.3%
vs FY2022
Sector context
#15 of 46
Health Care
What the data says
At $1.45, Charles River Laboratories's interest expense per share ranks #32 of 46 in the Health Care sector. Interest Expense per Share has fluctuated over the past 8 years, ranging from $0.59 in FY2016 to $1.71 in FY2022.
Based on SEC 10-K filings.
1.45 in FY2023 with a 5-year CAGR of +1.5%.
Increased from $1.22 to $1.45 over the past 2 years.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- +3.6%
- 5-Year CAGR
- +1.5%
- 10-Year CAGR
- -
Sector benchmark
#32 of 46 in Health CareTop 67% of 46This company $1.45 Sector average $1.36
▼
+6.9% above sector average
Key checks
Key Insights
- In FY2023, interest expense per share decreased 15.3% year-over-year.
- Ranks #15 out of 46 companies in the Health Care sector.
- Peak interest expense per share was recorded in FY2022.
- Lowest interest expense per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 1.10 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $1.45 | -15.3% |
| FY2022 | $1.71 | +40.0% |
| FY2021 | $1.22 | -6.1% |
| FY2020 | $1.30 | +111.0% |
| FY2019 | $0.62 | -54.1% |
| FY2018 | $1.35 | +114.0% |
| FY2017 | $0.63 | +6.0% |
| FY2016 | $0.59 | +33.9% |
As of FY2023 · SEC 10-K · Updated Jul 4, 2026